Parth Mehrotra - 02 Mar 2023 Form 4 Insider Report for Privia Health Group, Inc. (PRVA)

Role: President and COO
Signature: /s/ Thomas Bartrum, as attorney-in-fact
Issuer symbol: PRVA
Transactions as of: 02 Mar 2023
Net transactions value: -$2,647,737
Form type: 4
Filing time: 06 Mar 2023, 15:39:12 UTC
Previous filing: 02 Mar 2023
Next filing: 13 Mar 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	PRVA	Common Stock, $0.01 par value per share	Options Exercise	$96,946	+48,473	+50%	$2.00^*	145,864	02 Mar 2023	Direct
transaction	PRVA	Common Stock, $0.01 par value per share	Sale	$1,374,210	-48,473	-33%	$28.35	97,391	02 Mar 2023	Direct	F1, F2
transaction	PRVA	Common Stock, $0.01 par value per share	Options Exercise	$103,054	+51,527	+53%	$2.00^*	148,918	03 Mar 2023	Direct
transaction	PRVA	Common Stock, $0.01 par value per share	Sale	$1,355,143	-47,449	-32%	$28.56	101,469	03 Mar 2023	Direct	F1, F3
transaction	PRVA	Common Stock, $0.01 par value per share	Sale	$118,384	-4,078	-4%	$29.03	97,391	03 Mar 2023	Direct	F1, F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	PRVA	Stock Option (Right to Purchase)	Options Exercise	$0	-48,473	-12%	$0.000000	352,144	02 Mar 2023	Common Stock	48,473	$2.00	Direct	F5
transaction	PRVA	Stock Option (Right to Purchase)	Options Exercise	$0	-51,527	-15%	$0.000000	300,617	03 Mar 2023	Common Stock	51,527	$2.00	Direct	F5

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 15, 2022.
F2	The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $28.00 to $28.73 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
F3	The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $28.00 to $28.99 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
F4	The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $29.00 to $29.09 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
F5	All stock options are fully vested and exercisable.